1Castano EM,Roher AE,Esh CL,et al.Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed A]zheimer's disease and non-demented elderly subject[J].Neurol Res,2006 ;28 (2):155 -63.
2Davidseon P,Sjngren M.The use of proteomies in biomarker discovery in neurodegenerative diseases[J].Dis Markers,2005 ;21 (2):81-9.
3Puchades M,Hansson SF,Nilsson CL,et al.Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease[J].Brain Bes Mol Brain Res,2003 ;118(1-2):140-6.
4Soreghan BA,Lu BW,Thomas SN,et al.Using proteomics and network analysis to elucidate the consequences of synaptic protein oxidation in a PS1 + AbetaPP mouse model of Alsheimer's disease[J].J Alzheimers Dis,2005 ;8(3):227-41.
5Choi J,Forster M J,McDonald SR,et al.Proteomic identification of specific oxidized proteins in ApeE-knockout mice:relevance to Alzheimer's disease[J].Free Redic Biol Med,2004;36(9):1155-62.
6Sultana R,Perlnigi M,Buttefield DA.Redox proteomics identification of oxidatively modified proteins in Alzheimer's disease brain and in vivo and in vitro models of AD centered around Abeta(1-42)[J].J Chromatogr B Analyt Technol Biomed Life Sci,2006 ;833(1):3-11.
7Sultana R,Boyd-Kimball D,Poon HF,et al.Oxidative modification and down-regulation of Pin1 in AIzheimer's disease hippocampus:A redox proteomics analysis[J].Neurobiol Aging,2006;27(7):918-25.
8Butterfield DA,Poon HF,St Clair D,et al.Redex proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impainnont:insights into the development of Alzheimer's disease[J].Nonrobiol Dis,2006 ; 22 (2):223 -32.
9Korolainen MA,Aurinla S,Nyman TA,et al.Preteomic analysis of glial fibrillary acidic protein in Alzheimer's disease and aging brain[J].Nonrobiol Dis,2005 ;20(3):858-70.
10Castegna A,Thongboonkerd V,Klein JB,et al.Proteomic identification of nitrated proteins in ALzheimer's disease brain[J].J Neurochem,2003;85(6):1394-401.
